 WASHINGTON, July 28, 2021 PRNewswire -- Vanda Pharmaceuticals Inc. Vanda Nasdaq: VNDA today announced financial and operational results for the second quarter ended June 30, 2021. Vanda had another outstanding quarter of commercial revenue growth as we resumed activity across a number of our clinical programs. 